AI assistant
BIO-TECHNE Corp — Director's Dealing 2023
Aug 17, 2023
30718_dirs_2023-08-17_ae3cf890-42f5-4c8b-a9f4-b63a54dd53f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-15
Reporting Person: Hippel James (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | Restricted Stock Units | $ | A | 12798 | Acquired | Common Stock (12798) | Direct | |
| 2023-08-15 | Stock Options (Right to Buy) | $84.61 | A | 34442 | Acquired | 2030-08-15 | Common Stock (34442) | Direct |
| 2023-08-15 | Stock Options (Right to Buy) | $84.61 | A | 45923 | Acquired | 2030-08-15 | Common Stock (45923) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 57561 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $31.26 | 2024-08-09 | Common Stock (189156) | 189156 | Direct |
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (72264) | 72264 | Direct |
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (96356) | 96356 | Direct |
| Stock Options (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (79744) | 79744 | Direct |
| Stock Options (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (106324) | 106324 | Direct |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (57440) | 57440 | Direct |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (33300) | 33300 | Direct |
| Restricted Stock Units | $ | Common Stock (12876) | 0 | Direct | |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (76588) | 76588 | Direct |
| Restricted Stock Units | $ | Common Stock (7780) | 7780 | Direct | |
| Stock Options (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (30400) | 30400 | Direct |
| Stock Options (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (40536) | 40536 | Direct |
| Restricted Stock Units | $ | Common Stock (10912) | 10912 | Direct | |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (33916) | 33916 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (45220) | 45220 | Direct |
Footnotes
F1: Fully exercisable.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F3: On 8/5/2023, the Board of Directors certified vesting of 12,876 performance RSUs.
F4: Options to purchase 57,440 shares are vested. Options to purchase 19,148 shares vest on 8/5/2024.
F5: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 20,268 shares are vested. Options to purchase 10,136 shares vest on 8/6/2024 and options to purchase 10,134 shares vest on 8/6/2025.
F7: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 11,304 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026 and options to purchase 11,308 shares vest on 8/15/2024.
F9: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/27, and options to purchase 11,480 shares vest on 8/15/2026.